Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.
2014 World Health Organization
Seromucinous
atypical proliferative mucinous tumors
borderline tumors
mucinous
prognosis
recurrence
Journal
In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809
Informations de publication
Date de publication:
Historique:
received:
18
01
2020
revised:
29
01
2020
accepted:
31
01
2020
entrez:
2
5
2020
pubmed:
2
5
2020
medline:
13
2
2021
Statut:
ppublish
Résumé
To examine the clinicopathological features of ovarian seromucinous borderline tumors (SMBTs) and compare them with those of mucinous borderline/atypical proliferative mucinous tumors (MB/APMTs). Patients with SMBT between 2014 and 2018 and those with MB/APMT between 1988 and 2018 who underwent surgery at our Institution were identified. Pathological review was conducted using the 2014 World Health Organization criteria. Clinical features were compared retrospectively between SMBT and MB/APMT. In total, 11 (12.9%) patients with SMBT and 74 (87.1%) patients with MB/APMT were included in our study. The diagnosis of six patients with SMBT and 73 patients with MB/APMT was not revised on review. SMBT was diagnosed at a younger age (p=0.04), was of smaller size (p<0.01) and bilateral (p=0.03), coexisted with endometriosis (p<0.01), and more frequently recurred than MB/APMT (p=0.04). SMBT might be more aggressive than MB/APMT.
Identifiants
pubmed: 32354928
pii: 34/3/1341
doi: 10.21873/invivo.11911
pmc: PMC7279789
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1341-1346Informations de copyright
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Références
Int J Gynecol Pathol. 2006 Jan;25(1):83-9
pubmed: 16306790
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:15-30
pubmed: 28277307
Am J Surg Pathol. 2002 Dec;26(12):1529-41
pubmed: 12459620
Cancer. 1988 Jan 15;61(2):340-8
pubmed: 3334969
Ann Diagn Pathol. 2017 Apr;27:28-33
pubmed: 28325358
Int J Gynecol Cancer. 2015 Jan;25(1):49-54
pubmed: 25405578
Best Pract Res Clin Obstet Gynaecol. 2012 Jun;26(3):325-36
pubmed: 22321906
Gynecol Obstet Invest. 2013;76(4):241-7
pubmed: 24192519
Gynecol Oncol. 2006 Jan;100(1):185-91
pubmed: 16216320
Am J Surg Pathol. 2004 Oct;28(10):1311-8
pubmed: 15371946
Gynecol Obstet Invest. 2015 Jun 6;:
pubmed: 26067608
Int J Gynecol Cancer. 2018 Nov;28(9):1643-1649
pubmed: 30365456
Int J Gynecol Pathol. 2005 Apr;24(2):138-46
pubmed: 15782070
Am J Surg Pathol. 2011 May;35(5):625-32
pubmed: 21412130
Abdom Imaging. 2015 Aug;40(6):1753-60
pubmed: 25504376
Zhonghua Zhong Liu Za Zhi. 2017 Aug 23;39(8):589-594
pubmed: 28835081
Eur J Cancer. 2015 Mar;51(5):620-31
pubmed: 25661104
Gynecol Obstet Invest. 2018;83(1):65-69
pubmed: 28689208
Pathol Int. 1996 Aug;46(8):575-80
pubmed: 8893226
Hum Pathol. 2009 Jul;40(7):965-74
pubmed: 19269675
Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:38-42
pubmed: 25463633
Ann Surg Oncol. 2011 Jan;18(1):40-8
pubmed: 20737216
Adv Anat Pathol. 2013 Jan;20(1):45-52
pubmed: 23232571
Hum Reprod. 2011 Aug;26(8):2008-14
pubmed: 21511712